HD-OPM Archive
Topics › Lifestyle

Alcohol, smoking & vaping

36 posts (30 primarily about this topic) · 11 reposts and set-aside posts not shown

Start here — the best posts in this topic

  1. PREDIMED follow-up: mild-to-moderate wine linked to 50% lower CV risk, not proven causal Jun 10, 2025
  2. Medscape: cannabis users had about 6x the heart attack risk in a retrospective study Mar 27, 2025
  3. Meta-analysis of 4.3 million: moderate wine not linked to higher overall cancer risk ↩ 3 · Jan 05, 2025
  4. Harvard: 100+ cohorts show 25-40% lower CVD risk with light-to-moderate alcohol ↩ 7 · Dec 03, 2023
  5. NASEM alcohol review: moderate drinking tied to lower all-cause and CVD mortality Sep 30, 2025
  6. AHA statement: low alcohol shows no risk to possible benefit, heavy drinking harms ↩ 2 · Jun 10, 2025
  7. Upcoming RCT will test red wine vs CVD; Louis explains why he drinks mild red wine Jun 10, 2025
  8. UNATI trial will test red wine versus abstaining as if alcohol were a medication ↩ 1 · Aug 08, 2026
#alcohol 28#wine 14#cancer 7#predimed 6#smoking 5#mediterranean 4#harvard 4#breastcancer 4#diabetes 4#cvd 2#aha 2#cardiovasculardisease 2#publichealth 2#unati 2#taurine 2#nicotine 2#addiction 2#glp1 2#bloodpressure 2#cardiovascular 2#dementia 2#hypertension 2#meirstampfer 2#mendelianrandomization 2#mrhd 2#heartattack 1#mortality 1#mice 1#alphasynuclein 1#hormesis 1#parkinsons 1#semaglutide 1#a1c 1#insulin 1#insulinresistance 1#ldl 1#cardiovascularhealth 1

PREDIMED follow-up: mild-to-moderate wine linked to 50% lower CV risk, not proven causal

Jun 10, 2025 · Louis Nervegna ♥ 22 · 💬 37

Louis describes a PREDIMED follow-up that tracked wine intake via a urinary tartaric acid biomarker. Mild-to-moderate wine consumption over a 9-year follow-up was associated with lower heart attack, stroke, heart failure and CV mortality, but he stresses causation is unproven and alcohol's role is actively debated.

Meta-analysis of 4.3 million: moderate wine not linked to higher overall cancer risk

Jan 05, 2025 · Louis Nervegna ♥ 15 · 💬 17 ↩ 3

Louis shares Dr. Brian Lawenda's post on a Frontiers in Nutrition meta-analysis of 73 studies, covering over 4.3 million participants, that found moderate wine consumption (up to one drink/day for women, two for men) was not associated with increased overall cancer risk and might lower some cancer types. The post questions treating wine like beer and spirits.

Harvard: 100+ cohorts show 25-40% lower CVD risk with light-to-moderate alcohol

Dec 03, 2023 · Louis Nervegna ♥ 6 · 💬 22 ↩ 7

Louis quotes Harvard's Nutrition Source: more than 100 prospective studies show light-to-moderate drinking is linked to a 25-40% lower risk of heart attack, ischemic stroke, peripheral vascular disease, sudden cardiac death and CVD death, and Harvard epidemiologists consider it almost certainly causal. Above 4 drinks a day, risks of hypertension, arrhythmia, stroke, heart attack and death rise. An NIH-funded alcohol trial was stopped. This view is contested and observational.

NASEM alcohol review: moderate drinking tied to lower all-cause and CVD mortality

Sep 30, 2025 · Louis Nervegna ♥ 7 · 💬 14

The National Academies' evidence review on alcohol and health, published in JAMA on September 30, 2025, graded certainty using the USPSTF framework. It reached three moderate-certainty conclusions, including that moderate drinking is associated with lower all-cause and cardiovascular mortality, while stressing biases and the known harms of heavy drinking.

AHA statement: low alcohol shows no risk to possible benefit, heavy drinking harms

Jun 10, 2025 · Louis Nervegna ♥ 11 · 💬 9 ↩ 2

Louis quotes the 2025 AHA scientific statement on alcohol and cardiovascular disease. Low intake (up to 1 to 2 drinks per day) is associated with no risk to possible risk reduction for CAD, stroke, sudden death and possibly heart failure, whereas binge or 3+ drinks per day is consistently linked with worse outcomes across every CVD entity.

Upcoming RCT will test red wine vs CVD; Louis explains why he drinks mild red wine

Jun 10, 2025 · Louis Nervegna ♥ 17 · 💬 7

Louis announces a planned 5-year randomized trial of red wine and cardiovascular disease, run in PREDIMED style by the same principal investigator, with cancer and all-cause mortality as secondary endpoints. Meanwhile he drinks red wine several days a week, citing PREDIMED data where a biomarker of mild-to-moderate wine intake was linked to 50% lower risk. This is a personal view, not proof of benefit.

How the liver metabolizes alcohol and why a few drinks linger

Nov 07, 2025 · Louis Nervegna ♥ 17 · 💬 7

Louis shares a summary of alcohol metabolism, in which more than 90% of ethanol is processed in the liver and converted to the more toxic acetaldehyde before ALDH2 detoxifies it. He advises keeping any alcohol to small amounts.

UNATI: 10,000-person randomized trial of moderate red wine vs reducing alcohol

Aug 10, 2026 · Louis Nervegna ♥ 15 · 💬 3 ↩ 1

UNATI, led by Martinez-Gonzalez, will randomize about 10,000 drinkers (men 50-70, women 55-75, 3-40 drinks per week) to reduce alcohol or drink moderately (under 7/week women, under 14/week men, red wine with meals) for about 4 years. Outcomes include mortality, cardiovascular disease, cancer, diabetes and dementia.

A 5-year randomized trial of daily red wine vs alcohol-free drink is under way

Dec 16, 2025 · Louis Nervegna ♥ 11 · 💬 6

Louis highlights an upcoming large randomized trial from Miguel Martinez-Gonzalez's group (University of Navarra) that will test daily wine against an alcohol-free alternative for 5 years on cardiovascular disease, cancer and all-cause mortality. He argues only an RCT can settle the question of moderate alcohol and health.

Why smokers have 40-60% lower Parkinson's risk: low-dose carbon monoxide hypothesis

Oct 03, 2026 · Louis Nervegna ♥ 10 · 💬 6

The post explains that prospective studies show smokers have a much lower Parkinson's risk and that newer research points to very low-dose carbon monoxide rather than nicotine, possibly via HO-1 induction. He stresses there is no safe way to inhale CO and smoking is harmful, and suggests dietary strategies that trigger HO-1 instead.

Alcohol does not raise LDL and may lower it slightly, new study shows

Apr 11, 2025 · Louis Nervegna ♥ 13 · 💬 5

Louis shares an NEJM Clinician item on a new study of alcohol's effect on cholesterol, stating that many studies show alcohol does not raise LDL and actually lowers it by a very small amount. Study details are not given in the post.

New 5-year RCT from the PREDIMED lead investigator will test red wine versus CVD

Dec 12, 2023 · Louis Nervegna ♥ 8 · 💬 3 ↩ 7

Louis describes a funded randomized trial at the University of Navarra led by PREDIMED's principal investigator, which will randomize physicians aged 50-75 to moderate red wine or an alcohol-free alternative for five years, with cancer and all-cause mortality as secondary endpoints. He reviews PREDIMED's finding of 30% lower CVD with a Mediterranean diet including wine, and that the Mediterranean diet loses up to 23.5% of its protective effect without wine, per Martinez-Gonzalez. Results are not yet available.

Meta-analysis of 76 studies finds no link between wine drinking and cancer risk

Dec 03, 2023 · Louis Nervegna ♥ 3 · 💬 5 ↩ 3

Louis highlights a Frontiers in Nutrition systematic review and meta-analysis of 76 epidemiological studies, which found no association between wine consumption and any cancer and a protective trend for pancreatic, skin, lung, brain and overall cancer. He cautions that observational data cannot prove wine is harmless, and advises staying within guidelines of at most 2 drinks a day for men and 1 for women.

AHA: up to 1-2 drinks a day shows no risk to possible benefit; heavy drinking is harmful

Nov 06, 2025 · Louis Nervegna ♥ 8 · 💬 1

Louis argues alcohol and CVD claims should rely on evidence, citing decades of prospective studies and the AHA's statement that low intake (no more than 1-2 drinks daily) carries no risk to possible benefit, while 3 or more drinks daily is consistently worse. He notes a randomized red wine trial is underway.

Harvard researchers: alcohol effects are nuanced, with heavy drinking clearly harmful

Nov 08, 2025 · Louis Nervegna ♥ 6 · 💬 1

Louis shares a Harvard Chan School piece by alcohol researchers who argue data do not justify sweeping claims on moderate drinking. They say modest drinking likely raises risk for some diseases like breast and esophageal cancer, heavy drinking is unequivocally harmful, and that simplistic narratives dominate.

Mendelian randomization is a poor tool for studying alcohol and CVD

Nov 06, 2025 · Louis Nervegna ♥ 3 · 💬 2 ↩ 1

Louis argues that Mendelian randomization is poorly suited to foods and drinks because no gene forces someone to drink, and variants like ALDH2 affect behavior and are ethnically clustered. He cites a critique using alcohol and cardiovascular disease as the example.

Harvard authors: Mendelian randomization is a weak tool for alcohol and heart disease

Apr 20, 2026 · Louis Nervegna ♥ 3 · 💬 1 ↩ 1

A summary of a 2020 Harvard-authored critique arguing that genetic instrumental variable analysis, using alcohol and cardiovascular disease as the example, rests on assumptions that are often violated and should be called what it is. Useful for interpreting MR studies claiming any alcohol is harmful.

Even light alcohol raises breast cancer risk, but high folate erased it in Nurses' Study

Nov 07, 2026 · Louis Nervegna ♥ 2

Louis shares a Walter Willett clip noting wine, beer and spirits all raise breast cancer risk at under one drink a day, replicated in over 100 studies. Louis adds that in the Harvard Nurses' Study the excess risk disappeared with higher folate intake or folic acid supplementation, so folate may matter for those who drink.